Best Clinics and Costs for Oncology in United Arab Emirates 2024

Biography Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following: Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy Breast cancer Solid tumor diagnosis Digestive cancer Gynecological cancer Lung cancer Genitourinary cancer Sarcoma Awards & Achievements Award from Himaya Foundations and University of Sharjah Research & Publications Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3. The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87. Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272. First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21

Work Experience Dr Soha has more than 16 years experience in Clinical Oncology from prestigious clinical oncology department (NEMROCK), Kasr Alainy Medical School, Faculty of Medicine, Cairo University, Egypt where she was worked from 2004 till 2019. Kasr Alainy Medical School NEMROCK center is one of the largest comprehensive cancer centers in Egypt and Middle East that deals with medical oncology and radiation therapy. It is a tertiary referral center affiliated with Cairo University. It recruits about 3,000 new cancer cases in addition to 10.000 follow up patients per year. Dr Soha has worked as specialist and lecturer of clinical oncology since 2008 and as a consultant and assistant professor since 2013. Dr Soha is highly experienced in the treatment of adult and pediatric cancer by chemotherapy, targeted therapy and immunotherapy. She also has experience in radiation therapy of different cancer sites and its complications. Dr Soha is a member of the European Society of Clinical Oncology (ESMO) & a member of the American Society of Clinical Oncology (ASCO). Languages Spoken Arabic English Special Interests Breast Cancer Gynecological tumors Thoracic tumors Gastrointestinal tumors Hematological tumors Pediatric tumors Head and neck tumors Research / Publications Soha Talima, Hebtallah Kassem, Nemaat Kassem. Chemotherapy and targeted therapy for breast cancer with hepatitis C virus infection. Breast Cancer 2019 Mar; 26(2): 154-163. Amal Ahmed, Heba Omar, Soha Talima, et al. Single nucleotide polymorphism in adiponectin gene of pancreatic adenocarcinoma. Asian Pac j Cancer Prev, 20(1), 139-143 Mohamed AA, Aref Am, Talima S, et al. Association of serum level of vitamin D and VDR polymorphism Fok1 with the risk of survival of pancreatic cancer in Egyptian population. Indian J Cancer 2019. June; 56 (2): 130-134. S. Talima, M. Daly. Male breast cancer: NEMROCK cancer experience. ESMO. 2017 May 4-6 Belgim. Abstract Talima S, Khafagy H. Pathological complete response in obese patients receiving neoadjuvant chemotherapy for breast cancer. Tumori Journal BGICS Abstract Book 2018. Vol 104. Talima S, Al daly M, Alhogaraty E. Axillary Irradiation in breast cancer. Does meticulous contouring make a difference? Tumori Journal BGICS Abstract book 2018. Mohamed G, Talima S, Li L, Wej W, Rudzki Z, ET AL. Low expression and promoter hyper methylation of the tumor suppressor SLIT2 are associated with adverse patient outcomes in diffuse large B cell lymphoma. Path.Oncol Res. Jul; 25(3):1223-1231. Soha. M. Talima, Mohamoud H. Effect of chemotherapy on the nutritional status of Egyptian patients with breast cancer. Research In Oncology; December 2016 Hanaa A, Noha Y, Soha M. Second Line Chemotherapy in advanced non-small cell lung cancer; single institution experience M.Kamaleldin, M Al Daly, S. Talima. VMAT in locally advanced lung cancer; does it add benefit? Radiotherapy and Oncology. April 2016 volume 119, supplement 1, pages s783-784. Soha M. Talima, Moustafa AL Daly, Mohammed Hammam, Ahmed Bader. Children exposed to Treatment in Utero in Pregnant Patients with Breast Cancer; Experience from Two Large Egyptian Hospitals. Research In Oncology, 2018. Soha Mohammed Talima. Adjuvant chemotherapy for elderly (>65 years) breast cancer patients: a retrospective study. Cancer Biology 2018; 8(3). N.Y. Ibrahim, S.M. Talima, D. Y. Naguib. Obesity and prognosis in breast cancer; Annals Of Oncology. October 2019

r. Chetan Prakash MBBS, D-Ortho, DNB (Ortho) Specialist Orthopedic Surgeon Work Experience   Dr. Chetan Prakash has worked with many prestigious hospitals abroad as an orthopaedic surgeon. He underwent advanced training in hip and knee replacements, revision surgery & hip resurfacing from the prestigious Cleveland Clinic & Euclid Clinic in USA. He has also completed a Fellowship in Orthopaedic Surgery and Sports Traumatology from Kanto Hospital Bruderholz in Basel, Switzerland. Dr Prakash performed extensive internal fixation in trauma deformity correction in poliomyelitis, limb lengthening, Ilizarov fixation, interlocking nails and various hip prosthesis. He completed his MBBS from LLRM Medical College in Meerut, India. Later on, he did his D.Ortho from Kasturba Medical College in Manipal and DNB (Ortho) from St. Stephens Hospital in New Delhi. Languages Spoken English Arabic Hindi Special Interests Sports injuries including Knee – Key hole Surgeries. Ilizarov external fixator in poliomyelitis, limb lengthening and trauma. Correction of deformities in poliomyelitis, limb lengthening and ambulation. Interlocking nails for femur, tibia and humerus. Hip and knee arthroplasty, revision surgeries, hip resurfacing etc. Research / Publications Dr. Chetan did his research thesis during his DNB Orthopaedic training - "Evaluation of limb lengthening in patients of post polio residual paralysis by Ilizarov external ring fixator". Publications in all international journals with wide appreciations.